RLF *BUY*

Suspecting approval of Rafael’s lead AMD compound, CPI-613® (devimistat).
Beyond Technical AnalysisbiotechbiotechnologyBullish PatternsTechnical IndicatorsLONGpharmaceuticalsscienceTrend Analysis

他のメディア:

免責事項